39 studies found for:    Tardive Dyskinesia
Show Display Options
RSS Create an RSS feed from your search for:
Tardive Dyskinesia
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder
Condition: Tardive Dyskinesia
Interventions: Drug: NBI-98854;   Drug: Placebo
2 Completed Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia
Condition: Neuroleptic-Induced Tardive Dyskinesia
Interventions: Drug: risperidone;   Drug: olanzapine
3 Completed Melatonin Treatment for Tardive Dyskinesia in Schizophrenia
Condition: Tardive Dyskinesia
Interventions: Drug: Melatonin;   Drug: Placebo
4 Completed Extract of Ginkgo Biloba and Tardive Dyskinesia
Conditions: Tardive Dyskinesia;   Schizophrenia
Interventions: Drug: Extract of Ginkgo Biloba (EGb-761 capsules);   Drug: Placebo
5 Completed Tardive Dyskinesia and Cognitive Function
Conditions: Tardive Dyskinesia;   Neurocognitive Function
Interventions: Drug: amisulpride;   Drug: Olanzapine;   Drug: Conventional antipsychotics
6 Unknown  Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Dietary Supplement: Omega-3 fish oil capsules (including DHA);   Dietary Supplement: Placebo
7 Completed Treatment of Tardive Dyskinesia With Galantamine
Condition: Tardive Dyskinesia
Intervention: Drug: Galantamine
8 Completed NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Drug: NBI-98854;   Drug: Placebo
9 Completed Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia
Condition: Tardive Dyskinesia
Intervention: Drug: NBI-98854
10 Completed Piracetam for Treatment Tardive Dyskinesia
Condition: Tardive Dyskinesia
Intervention: Drug: piracetam
11 Terminated Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Drug: Pyridoxal 5'-Phosphate;   Drug: Placebo
12 Completed NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Condition: Tardive Dyskinesia
Interventions: Drug: NBI-98854;   Drug: Placebo
13 Recruiting A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia
Condition: Drug-induced Tardive Dyskinesia
Interventions: Drug: Acamprosate calcium;   Drug: Placebo
14 Completed Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia
Condition: Dyskinesia, Medication-induced
Intervention: Drug: Levetiracetam
15 Recruiting D-Serine Treatment For Tardive Dyskinesia
Conditions: Schizophrenia and Schizoaffective Disorder;   Tardive Dyskinesia
Intervention: Dietary Supplement: D-serine
16 Not yet recruiting Reducing Involuntary Movements in Tardive Dyskinesia
Condition: Tardive Dyskinesia
Intervention: Drug: SD-809
17 Recruiting Aim to Reduce Movements in Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Drug: SD-809;   Drug: Placebo
18 Terminated Sarizotan in the Treatment of Neuroleptic-Induced Tardive Dyskinesia
Condition: Neuroleptic-Induced Tardive Dyskinesia
Intervention: Drug: Sarizotan
19 Withdrawn Pyridoxal Kinase Activity in Tardive Dyskinesia
Condition: Tardive Dyskinesia
Intervention: Drug: Pyridoxine
20 Completed Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia
Conditions: Dyskinesia;   Schizophrenia
Intervention: Drug: eicosapentaenoic acid

Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results
Indicates status has not been verified in more than two years